Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews


Print Page Follow BioNews on Twitter BioNews RSS feed

Like the Progress Educational Trust on Facebook







Heart failure patients' skin cells turned into beating heart muscle

28 May 2012

By Helen Brooks

Appeared in BioNews 658

For the first time, scientists have managed to turn heart attack patients' skin cells into healthy beating heart cells in the lab.

Previously, the technique had only been successful using skin cells from young and healthy people. This research, published in the European Heart Journal, marks the first time it has worked for skin cells from elderly patients and those with heart disease.

Professor Lior Gepstein, of Technion-Israel Institute of Technology and Rambam Medical Center in Haifa, Israel, who led the research explains that the beating cells are 'healthy and young - the equivalent to the stage of his heart cells when he was just born'.

The ability to use heart failure patients' own, reprogrammed cells would theoretically stop them being rejected by their immune systems.

The researchers took skin cells from two elderly male heart failure patients and reprogrammed them by delivering three genes to the cell's nucleus along with a small molecule called valproic acid. The resulting cells are called human induced pluripotent stem cells (hiPSCs), which have the ability to become any cell type in the body.

In this case, the scientists transformed them into heart muscle cells, which were grown with healthy cardiac tissue. After 24 hours the tissues started beating together in a Petri dish, 'like a tiny microscopic cardiac tissue comprised of approximately 1000 cells in each beating area', according to Professor Gepstein.

Lastly, the engineered tissue was transplanted into healthy rat hearts and the researchers saw that the grafted tissue was establishing connections with the host tissue.

However, much more extensive research is required before this technology is seen in the clinic.

Dr Marrick Kukin, director of the Heart Failure Program at St Luke's-Roosevelt Hospital in New York, who was not involved in the study told ABC news: 'It is very exciting and very interesting, but we are far away from taking this to patients'.

He added that the study only involved two patients, and that the cells were transplanted into healthy rat hearts with no signs of heart failure, asking: 'Will it work in heart muscle that's dead?'.

There are still a number of major experiments that need to take place before testing out this therapy in humans, Kukin added, including studies on mammals and in animals whose hearts have been damaged.

Dr Shephal Doshi, director of electrophysiology and pacing at Saint John's Health Center in Santa Monica, USA, who was not involved in the study told the LA times: 'What we produce in an animal model or in a Petri dish is hardly what happens in a human. This is a first step. It will take five, ten, 15, maybe 20 years to reach fruition at the soonest'.

 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

28 April 2014 - by Dr Lanay Tierney 
An advanced 3D skin model developed at King's College London (KCL) may reduce the need for animal models in cosmetic testing.... [Read More]
06 January 2014 - by Dr Louisa Petchey 
The same genetic variant that makes some people more prone to stress has been shown to increase the risk of having and dying from a heart attack... [Read More]
17 December 2012 - by Alison Cranage 
Scientists have converted kidney cells from human urine into brain cells, bypassing the need for embryonic stem cells... [Read More]
03 December 2012 - by Greg Ball 
Induced pluripotent stem (iPS) cells have been created from a routine blood sample by researchers at the University of Cambridge in the UK, marking an improvement over existing experimental methods that require more invasive tissue biopsies.... [Read More]
24 September 2012 - by James Brooks 
The biological basis of a rare congenital disorder has been clarified, thanks to stem cell technology. The researchers say their work shows how advances in stem cell science can provide insights into genetic conditions... [Read More]

30 April 2012 - by Helen Brooks 
Scar tissue formed after a heart attack could be repaired without the use of stem cells, according to US scientists... [Read More]
05 March 2012 - by Cathy Holding 
A major clinical trial to investigate a stem cell treatment for chronic ischemic heart disease (IHD) – a leading cause of death around the world – has begun in the US... [Read More]
20 February 2012 - by Cathy Holding 
A stem cell-based therapy aiming to reverse the damage caused by heart attacks has shown positive results in an early clinical trial... [Read More]
05 December 2011 - by Dr Louisa Petchey 
Research in mice has shown the heart contains its own renewable source of stem cells which can differentiate into a variety of cell types. The research team in Australia hopes that one day the stem cells could be activated so a broken heart can be made to mend itself.... [Read More]
12 September 2011 - by Rosie Beauchamp 
An Australian company has announced it has received regulatory approval from the European Medicines Agency (EMA) to begin phase II trials for its cardiovascular stem cell treatment, Revascor.... [Read More]

HAVE YOUR SAY
Be the first to have your say.

You need to Login or Register to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions

 


 

- click here to enquire about using this story.

Printer Friendly Page

Published by the Progress Educational Trust
PET CONFERENCE
COMMERCIALISATION OF LIFE


'The Commercialisation of Life', Progress Educational Trust conference, central London, Tuesday 2 December 2014 - book HERE

London, 2 December
Click HERE for details

Advertise your products and services HERE - click for further details

Good Fundraising Code

Become a Friend of PET HERE, and give the Progress Educational Trust a regular donation